Profile
Steve Westing has been Vice President of Medical and Scientific Development for OccuLogix, Inc. since April 10, 2006.
Previously, he was Associate Director-Advisory and Thought Leader Services and a Member of the Ophthalmology Commercial Strategy Team for Genentech, Inc. Prior to joining Genentech in May 1996, Dr. Westing worked at Loredan Biomedical, Inc. since May 1990.
He received a PhD in Muscle Physiology from The Karolinska Institute, Stockholm, Sweden.
Former positions of Steve Westing
| Companies | Position | End |
|---|---|---|
| TEARLAB CORPORATION | Chief Tech/Sci/R&D Officer | 2008-01-08 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Training of Steve Westing
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
TearLab Corp., Inc.
TearLab Corp., Inc. Medical SpecialtiesHealth Technology Develops point-of-care portable devices for measuring osmolarity to treat eye disorders | Health Technology |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Steve Westing
















